PODXL and cancer: Since the core protein of PODXL is aberrantly expressed by many human tumors and its expression is consistently linked to poor prognosis (reviewed in (4, 8, 14, 17, 18)), this PODO447 epitope serves as an excellent candidate for the development of targeted cancer immunotherapies.